Background Accumulating evidence suggests a beneficial effective of tumour necrosis factor‐
alpha (TNF‐α) inhibitors on the outcomes of COVID‐19 disease, which, however is not …

Objectives This study aimed to evaluate the efficacy and adverse events of favipiravir in
patients with COVID-19. Methods Our protocol was registered on PROSPERO …

Abstract The SARS-CoV-2 virus ACE-2 receptor utilization for cellular entry and the defined
ACE-2 receptor role in cardiovascular medicine hinted at dysregulated endothelial function …

Systemic autoimmune diseases (SAD) are a heterogeneous group of diseases with a
common aetiopathogenic basis affecting all ages characterised by a systemic phenotypic …

Initial case series of small number of patients at the beginning of the pandemic reported a
rather guarded prognosis for Behçet's syndrome (BS) patients infected with SARS-CoV-2. In …

Objectives To present the clinical characteristics, disease course, management, and
outcomes of COVID-19 infection in patients with Behcet's disease (BD). Methods In this …

This review aims to provide a critical digest of the recent studies that enhance our
understanding of Behçet's syndrome by evaluating time trends, differences in disease …

Objectives The aim of this study is to investigate the outcomes of coronavirus disease 2019
(COVID-19) in our cohort of Behçet's disease (BD) patients and to reveal the rate of BD …

1 Galván Casas C, Catala A, Carretero Hernández G et al. Classification of the cutaneous
manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with …

Abstract Objective The implications of Covid-19 in patients with Behçet's disease (BD) are
unknown. Patients with BD usually take long-term therapy with therapeutic agents that have …